Fluorine in PDB 3tv6: Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
Enzymatic activity of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
All present enzymatic activity of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor:
2.7.11.1;
Protein crystallography data
The structure of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor, PDB code: 3tv6
was solved by
W.C.Voegtli,
H.L.Sturgis,
W.-I.Wu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.75 /
3.30
|
Space group
|
P 41 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
108.440,
108.440,
150.700,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
23.7 /
28.8
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
(pdb code 3tv6). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor, PDB code: 3tv6:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 3tv6
Go back to
Fluorine Binding Sites List in 3tv6
Fluorine binding site 1 out
of 4 in the Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:36.2
occ:1.00
|
F19
|
A:B0R1
|
0.0
|
36.2
|
1.0
|
C18
|
A:B0R1
|
1.4
|
35.6
|
1.0
|
C17
|
A:B0R1
|
2.4
|
34.2
|
1.0
|
C12
|
A:B0R1
|
2.4
|
36.6
|
1.0
|
C11
|
A:B0R1
|
3.0
|
39.0
|
1.0
|
N10
|
A:B0R1
|
3.1
|
42.0
|
1.0
|
N
|
A:LYS483
|
3.4
|
66.8
|
1.0
|
CB
|
A:LYS483
|
3.5
|
68.0
|
1.0
|
C14
|
A:B0R1
|
3.7
|
35.1
|
1.0
|
C16
|
A:B0R1
|
3.7
|
33.4
|
1.0
|
C
|
A:VAL482
|
3.7
|
65.5
|
1.0
|
CB
|
A:ALA481
|
3.7
|
61.7
|
1.0
|
OG1
|
A:THR529
|
3.8
|
50.0
|
1.0
|
C
|
A:ALA481
|
3.8
|
62.6
|
1.0
|
O
|
A:ALA481
|
3.9
|
62.5
|
1.0
|
O13
|
A:B0R1
|
3.9
|
40.1
|
1.0
|
N
|
A:VAL482
|
3.9
|
63.7
|
1.0
|
CA
|
A:LYS483
|
3.9
|
68.2
|
1.0
|
O
|
A:ILE527
|
4.0
|
53.0
|
1.0
|
CA
|
A:VAL482
|
4.1
|
64.7
|
1.0
|
CG2
|
A:VAL471
|
4.1
|
75.0
|
1.0
|
C15
|
A:B0R1
|
4.2
|
33.9
|
1.0
|
O
|
A:VAL482
|
4.3
|
65.3
|
1.0
|
CG1
|
A:VAL471
|
4.3
|
75.2
|
1.0
|
C5
|
A:B0R1
|
4.3
|
45.2
|
1.0
|
CA
|
A:ALA481
|
4.4
|
61.9
|
1.0
|
CG2
|
A:THR529
|
4.6
|
49.8
|
1.0
|
CG
|
A:LYS483
|
4.7
|
67.1
|
1.0
|
CB
|
A:VAL471
|
4.7
|
75.2
|
1.0
|
CD
|
A:LYS483
|
4.7
|
65.6
|
1.0
|
CB
|
A:THR529
|
4.8
|
50.1
|
1.0
|
F20
|
A:B0R1
|
4.8
|
36.4
|
1.0
|
N
|
A:THR529
|
4.8
|
50.5
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 3tv6
Go back to
Fluorine Binding Sites List in 3tv6
Fluorine binding site 2 out
of 4 in the Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:36.4
occ:1.00
|
F20
|
A:B0R1
|
0.0
|
36.4
|
1.0
|
C14
|
A:B0R1
|
1.3
|
35.1
|
1.0
|
C12
|
A:B0R1
|
2.4
|
36.6
|
1.0
|
C15
|
A:B0R1
|
2.4
|
33.9
|
1.0
|
N21
|
A:B0R1
|
2.7
|
33.8
|
1.0
|
C11
|
A:B0R1
|
2.7
|
39.0
|
1.0
|
O13
|
A:B0R1
|
2.8
|
40.1
|
1.0
|
CD2
|
A:LEU514
|
3.2
|
38.5
|
1.0
|
N
|
A:ASP594
|
3.4
|
61.3
|
1.0
|
OD2
|
A:ASP594
|
3.5
|
64.5
|
1.0
|
CE1
|
A:PHE583
|
3.6
|
50.6
|
1.0
|
C18
|
A:B0R1
|
3.7
|
35.6
|
1.0
|
C16
|
A:B0R1
|
3.7
|
33.4
|
1.0
|
CA
|
A:GLY593
|
3.7
|
59.0
|
1.0
|
N10
|
A:B0R1
|
3.7
|
42.0
|
1.0
|
CZ
|
A:PHE583
|
3.8
|
51.0
|
1.0
|
C
|
A:GLY593
|
3.9
|
60.1
|
1.0
|
C17
|
A:B0R1
|
4.2
|
34.2
|
1.0
|
CA
|
A:ASP594
|
4.3
|
62.5
|
1.0
|
S22
|
A:B0R1
|
4.4
|
35.4
|
1.0
|
CG
|
A:ASP594
|
4.5
|
63.5
|
1.0
|
NZ
|
A:LYS483
|
4.6
|
65.2
|
1.0
|
CG
|
A:LEU514
|
4.7
|
38.5
|
1.0
|
CB
|
A:ASP594
|
4.7
|
62.5
|
1.0
|
CD1
|
A:PHE583
|
4.7
|
50.8
|
1.0
|
F19
|
A:B0R1
|
4.8
|
36.2
|
1.0
|
C5
|
A:B0R1
|
4.8
|
45.2
|
1.0
|
O27
|
A:B0R1
|
4.8
|
35.7
|
1.0
|
N
|
A:GLY593
|
4.9
|
57.3
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 3tv6
Go back to
Fluorine Binding Sites List in 3tv6
Fluorine binding site 3 out
of 4 in the Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1
b:36.4
occ:1.00
|
F19
|
B:B0R1
|
0.0
|
36.4
|
1.0
|
C18
|
B:B0R1
|
1.4
|
36.1
|
1.0
|
C17
|
B:B0R1
|
2.4
|
34.7
|
1.0
|
C12
|
B:B0R1
|
2.4
|
37.3
|
1.0
|
C11
|
B:B0R1
|
3.0
|
39.2
|
1.0
|
N10
|
B:B0R1
|
3.0
|
41.5
|
1.0
|
N
|
B:LYS483
|
3.5
|
53.7
|
1.0
|
CB
|
B:ALA481
|
3.5
|
50.4
|
1.0
|
CB
|
B:LYS483
|
3.5
|
54.3
|
1.0
|
C16
|
B:B0R1
|
3.7
|
34.1
|
1.0
|
C
|
B:ALA481
|
3.7
|
51.1
|
1.0
|
C14
|
B:B0R1
|
3.7
|
36.6
|
1.0
|
CG1
|
B:VAL471
|
3.7
|
56.6
|
1.0
|
O
|
B:ALA481
|
3.8
|
51.1
|
1.0
|
N
|
B:VAL482
|
3.9
|
51.8
|
1.0
|
OG1
|
B:THR529
|
3.9
|
44.9
|
1.0
|
O13
|
B:B0R1
|
3.9
|
39.9
|
1.0
|
C
|
B:VAL482
|
3.9
|
53.0
|
1.0
|
CA
|
B:LYS483
|
4.0
|
54.5
|
1.0
|
O
|
B:ILE527
|
4.1
|
45.4
|
1.0
|
C15
|
B:B0R1
|
4.2
|
34.9
|
1.0
|
CA
|
B:ALA481
|
4.2
|
50.6
|
1.0
|
C5
|
B:B0R1
|
4.2
|
45.0
|
1.0
|
CA
|
B:VAL482
|
4.2
|
52.5
|
1.0
|
CD
|
B:LYS483
|
4.6
|
52.0
|
1.0
|
CG
|
B:LYS483
|
4.7
|
53.3
|
1.0
|
CG2
|
B:THR529
|
4.7
|
44.0
|
1.0
|
CG2
|
B:VAL471
|
4.7
|
56.8
|
1.0
|
O
|
B:VAL482
|
4.7
|
53.1
|
1.0
|
CB
|
B:VAL471
|
4.7
|
56.9
|
1.0
|
F20
|
B:B0R1
|
4.8
|
38.3
|
1.0
|
CB
|
B:THR529
|
4.9
|
44.4
|
1.0
|
C6
|
B:B0R1
|
4.9
|
46.2
|
1.0
|
N
|
B:THR529
|
4.9
|
44.6
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 3tv6
Go back to
Fluorine Binding Sites List in 3tv6
Fluorine binding site 4 out
of 4 in the Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human B-Raf Kinase Domain in Complex with A Methoxypyrazolopyridinyl Benzamide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1
b:38.3
occ:1.00
|
F20
|
B:B0R1
|
0.0
|
38.3
|
1.0
|
C14
|
B:B0R1
|
1.4
|
36.6
|
1.0
|
C12
|
B:B0R1
|
2.4
|
37.3
|
1.0
|
C15
|
B:B0R1
|
2.4
|
34.9
|
1.0
|
C11
|
B:B0R1
|
2.7
|
39.2
|
1.0
|
O13
|
B:B0R1
|
2.7
|
39.9
|
1.0
|
N21
|
B:B0R1
|
2.7
|
33.5
|
1.0
|
N
|
B:ASP594
|
3.3
|
46.7
|
1.0
|
CD2
|
B:LEU514
|
3.4
|
28.7
|
1.0
|
CE1
|
B:PHE583
|
3.5
|
44.6
|
1.0
|
CZ
|
B:PHE583
|
3.6
|
44.5
|
1.0
|
C18
|
B:B0R1
|
3.7
|
36.1
|
1.0
|
C16
|
B:B0R1
|
3.7
|
34.1
|
1.0
|
N10
|
B:B0R1
|
3.7
|
41.5
|
1.0
|
CA
|
B:GLY593
|
3.9
|
44.4
|
1.0
|
CA
|
B:ASP594
|
4.0
|
47.8
|
1.0
|
C
|
B:GLY593
|
4.0
|
45.6
|
1.0
|
CB
|
B:ASP594
|
4.1
|
47.8
|
1.0
|
OD2
|
B:ASP594
|
4.1
|
49.8
|
1.0
|
C17
|
B:B0R1
|
4.2
|
34.7
|
1.0
|
S22
|
B:B0R1
|
4.4
|
33.0
|
1.0
|
CG
|
B:ASP594
|
4.5
|
48.4
|
1.0
|
CD1
|
B:PHE583
|
4.6
|
45.0
|
1.0
|
NZ
|
B:LYS483
|
4.7
|
51.9
|
1.0
|
C5
|
B:B0R1
|
4.7
|
45.0
|
1.0
|
C24
|
B:B0R1
|
4.8
|
28.7
|
1.0
|
CE2
|
B:PHE583
|
4.8
|
44.4
|
1.0
|
F19
|
B:B0R1
|
4.8
|
36.4
|
1.0
|
CG
|
B:LEU514
|
4.8
|
29.4
|
1.0
|
O27
|
B:B0R1
|
4.9
|
33.3
|
1.0
|
|
Reference:
S.Wenglowsky,
L.Ren,
K.A.Ahrendt,
E.R.Laird,
I.Aliagas,
B.Alicke,
A.J.Buckmelter,
E.F.Choo,
V.Dinkel,
B.Feng,
S.L.Gloor,
S.E.Gould,
S.Gross,
J.Gunzner-Toste,
J.D.Hansen,
G.Hatzivassiliou,
B.Liu,
K.Malesky,
S.Mathieu,
B.Newhouse,
N.J.Raddatz,
Y.Ran,
S.Rana,
N.Randolph,
T.Risom,
J.Rudolph,
S.Savage,
L.T.Selby,
M.Shrag,
K.Song,
H.L.Sturgis,
W.C.Voegtli,
Z.Wen,
B.S.Willis,
R.D.Woessner,
W.I.Wu,
W.B.Young,
J.Grina.
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: the Development of Selective, Orally Bioavailable, and Efficacious Inhibitors. Acs Med Chem Lett V. 2 342 2011.
ISSN: ISSN 1948-5875
PubMed: 24900315
DOI: 10.1021/ML200025Q
Page generated: Wed Jul 31 22:47:54 2024
|